These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37194793)

  • 1. Diagnostic potential of Type VII Collagen during oral carcinogenesis.
    Poomsawat S; Kariya A; Nimmanon T; Kosanwat T; Juengsomjit R; Sirima S
    J Appl Oral Sci; 2023; 31():e20220486. PubMed ID: 37194793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial and fibroblast SPARC expression patterns in oral leukoplakia and oral squamous cell carcinoma.
    Poomsawat S; Kosanwat T; Meesakul O; Sanguansin S
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Aug; 134(2):e44-e50. PubMed ID: 35165061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal aspects of type VII collagen: Implications for dystrophic epidermolysis bullosa and epidermolysis bullosa acquisita.
    Watanabe M; Natsuga K; Shinkuma S; Shimizu H
    J Dermatol; 2018 May; 45(5):515-521. PubMed ID: 29352483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stromal myofibroblasts in oral leukoplakia and oral squamous cell carcinoma.
    de-Assis EM; Pimenta LG; Costa-e-Silva E; Souza PE; Horta MC
    Med Oral Patol Oral Cir Bucal; 2012 Sep; 17(5):e733-8. PubMed ID: 22322518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant expression of p-Smad3 in oral carcinogenesis.
    Poomsawat S; Punyasingh J; Vejchapipat P
    Clin Oral Investig; 2015 Apr; 19(3):613-8. PubMed ID: 25035066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcellular localization and expression of E-cadherin and SNAIL are relevant since early stages of oral carcinogenesis.
    Lopes NM; Xavier FCA; Ortiz RC; Amôr NG; Garlet GP; Lara VS; Batista AC; Costa NL; Rodini CO
    Pathol Res Pract; 2018 Aug; 214(8):1185-1191. PubMed ID: 29970306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and oncogenic properties of membranous Notch1 in oral leukoplakia and oral squamous cell carcinoma.
    Ding X; Zheng Y; Wang Z; Zhang W; Dong Y; Chen W; Li J; Chu W; Zhang W; Zhong Y; Mao L; Song X; Wu Y
    Oncol Rep; 2018 Jun; 39(6):2584-2594. PubMed ID: 29620248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Value of Cytokeratin 17 during Oral Carcinogenesis: An Immunohistochemical Study.
    Sanguansin S; Kosanwat T; Juengsomjit R; Poomsawat S
    Int J Dent; 2021; 2021():4089549. PubMed ID: 34853592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semiquantifiable angiogenesis parameters in association with the malignant transformation of oral leukoplakia.
    Thiem DGE; Schneider S; Venkatraman NT; Kumar VV; Brieger J; Frerich B; Kämmerer PW
    J Oral Pathol Med; 2017 Oct; 46(9):710-716. PubMed ID: 28036153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of p16 in oral cancer and premalignant lesions.
    Buajeeb W; Poomsawat S; Punyasingh J; Sanguansin S
    J Oral Pathol Med; 2009 Jan; 38(1):104-8. PubMed ID: 19192055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel lncRNA LOLA1 may predict malignant progression and promote migration, invasion, and EMT of oral leukoplakia via the AKT/GSK-3β pathway.
    Liu W; Yao Y; Shi L; Tang G; Wu L
    J Cell Biochem; 2021 Oct; 122(10):1302-1312. PubMed ID: 33969929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMI-1 expression increases in oral leukoplakias and correlates with cell proliferation.
    Klein IP; Meurer L; Danilevicz CK; Squarize CH; Martins MD; Carrard VC
    J Appl Oral Sci; 2020; 28():e20190532. PubMed ID: 32348447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EZH2 promotes malignant phenotypes and is a predictor of oral cancer development in patients with oral leukoplakia.
    Cao W; Younis RH; Li J; Chen H; Xia R; Mao L; Chen W; Ren H
    Cancer Prev Res (Phila); 2011 Nov; 4(11):1816-24. PubMed ID: 21697275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of survivin and caspase 3 in oral carcinogenesis.
    Poomsawat S; Punyasingh J; Vejchapipat P
    Appl Immunohistochem Mol Morphol; 2014 Jan; 22(1):65-71. PubMed ID: 23531848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased ΔNp63 expression is predictive of malignant transformation in oral epithelial dysplasia and poor prognosis in oral squamous cell carcinoma.
    Matsubara R; Kawano S; Kiyosue T; Goto Y; Hirano M; Jinno T; Toyoshima T; Kitamura R; Oobu K; Nakamura S
    Int J Oncol; 2011 Dec; 39(6):1391-9. PubMed ID: 21833468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The p16 methylation in oral leukoplakia and oral squamous cell carcinoma].
    Liu HW; Hu BQ; Cao CF
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Mar; 40(2):94-7. PubMed ID: 15842853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of stromal myofibroblasts in oral leukoplakia, oral submucous fibrosis, and oral squamous cell carcinoma--an immunohistochemical study.
    Gupta K; Metgud R; Gupta J
    J Cancer Res Ther; 2015; 11(4):893-8. PubMed ID: 26881537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of Epstein-Barr virus-encoded latent membrane protein-1 (LMP-1) in oral squamous cell carcinoma.
    Rahman R; Poomsawat S; Juengsomjit R; Buajeeb W
    BMC Oral Health; 2019 Jul; 19(1):142. PubMed ID: 31291930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical evaluation of galectin-3 expression in oral squamous cell carcinoma, oral leukoplakia and normal mucosa.
    Selvaraj FM; Joseph AP; Varun BR; Mony V; Siva Kumar TT
    Indian J Dent Res; 2022; 33(3):282-286. PubMed ID: 36656189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between microRNA expression levels and histopathological features of dysplasia in oral leukoplakia.
    Brito JA; Gomes CC; Guimarães AL; Campos K; Gomez RS
    J Oral Pathol Med; 2014 Mar; 43(3):211-6. PubMed ID: 24020903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.